MedPath

Applying Liquid Skin Barrier Film to Prevent Skin Complications Around Indwelling Vascular Catheters in Pediatric Patients: a Randomized Controlled Trial

Not Applicable
Completed
Conditions
Skin Injury
Skin Allergy
Interventions
Device: Skin barrier film
Registration Number
NCT06192095
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Long-term indwelling vascular catheters including central venous catheters, peripherally inserted central venous catheters, arterial catheters are often essential for medical care. During the routine care, some patients may experience skin damage around the catheter insertion site due to allergic reactions to the catheter dressing material, physical damage during dressing changes, leading to infection, prolonged hospitalization, and unexpected medical costs. If the condition is mild, it may increase the number of dressing changes. In severe cases, it may require changing to a different dressing method, using medication, or even removing the indwelling catheter. This study investigates the efficacy of liquid skin barrier film in preventing skin damage around long-term indwelling vascular catheters. In this randomized controlled trial, the participants aged 0 to less than 18 years who has long-term indwelling vascular catheters inserted at National Taiwan University Hospital Yunlin Branch will be recruited. At the time of indwelling vascular catheter insertion, the subjects are randomly assigned to the control group or the experimental group. The control group received standard care according to the hospital's guidelines, using a sterile transparent dressing or gauze to cover the catheter insertion site. The experimental group first applied liquid skin barrier film to the skin, then applied a sterile transparent dressing or gauze to cover the catheter insertion site. The patients are followed for two weeks. The primary endpoint is the need for change of dressing, use of medication, or removal of the catheter due to skin damage around the catheter insertion site. The secondary endpoints are skin breakdown, number of dressing changes, and incidence of bloodstream infection. It is expected that the research results may change the standard clinical management of long-term indwelling vascular catheters.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Age 0-17 years (less than 18 years old)
  • Receiving a central venous catheter, peripherally inserted central catheter, or arterial line insertion
Exclusion Criteria
  • The skin around the catheter insertion site is not inact
  • Known allergic to liquid skin barrier film

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
With skin barrier filmSkin barrier filmRoutine care with preventive use of skin barrier film around the insertion site of a vascular indwelling catheter
Primary Outcome Measures
NameTimeMethod
Change of dressing method0-14 days

Change of dressing method due to injury/allergy of skin around the vascular indwelling catheters

Vascular indwelling catheter removal0-14 days

Need of catheter removal due to injury/allergy of skin around

Medical treatment for the skin0-14 days

Need of medical treatment (topical, oral, intravenous) due to injury/allergy of skin around the vascular indwelling catheters

Secondary Outcome Measures
NameTimeMethod
Catheter-related bloodstream infection0-14 days

Occurrence of catheter-related bloodstream infection

Pain degree/severity of the skin0-14 days

Pain degree of the skin around the vascular indwelling catheter

Occurrence of skin injury/allergy0-14 days

Skin injury/allergy of the skin around the vascular indwelling catheter

Number of dressing changes0-14 days

Total number of dressing changes of the vascular indwelling catheter

Trial Locations

Locations (1)

National Taiwan University Hospital Yunlin Branch

🇨🇳

Douliu, Yunlin, Taiwan

© Copyright 2025. All Rights Reserved by MedPath